AzTrials
AzTrials

NutritionNCT03321227

Effect of Eggs and Egg Components on Cognitive Performance and Appetite in School-aged Children

A study testing Snack skipping, Whole eggs and Egg whites in people with Nutrition and Cognitive Performance, run by Toronto Metropolitan University at 1 site in Canada.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of the present study is to determine the effects of eggs and egg components on cognitive performance and appetite in children aged 9-14 years, as well as to identify the underlying physiological mechanisms in this relationship. Read more about this study

Who is it for?
Ages 9 to 14 yearsHealthy volunteers can take part
Conditions the study is for
Nutrition, Cognitive Performance, Appetite
What is being tested?
Snack skipping, Whole eggs and Egg whites
Could I receive a placebo?
No, everyone receives an active treatment
How many people
19 participants
Where
1 siteCanada
Study dates
9 Apr 2018to 1 Dec 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 9 to 14 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • be between 9 and 14 years of age
  • be healthy, and have been born at term
  • healthy body weight (between the 5th and 85th BMI percentile for age and gender)

Who cannot join

  • children with food sensitivities or allergies to eggs, egg-products, dairy and wheat
  • children with any diagnosed learning, emotional, or behavioral disabilities
  • children on medications that may influence cognitive performance

Trial locations and contacts

1 site in 1 country.

Canada1 site
  • School of Nutrition, Ryerson University

    Toronto, Ontario, M5B 2K3

Other trials in Canada

About this study

The purpose of the present study is to determine the effects of eggs and egg components on cognitive performance and appetite in children aged 9-14 years, as well as to identify the underlying physiological mechanisms in this relationship.

Read the detailed description

Children will be asked to refrain from exercising the morning of their test day and inform researchers of any illness. Following a 12-hour overnight fast, children will consume a standardized breakfast of a cereal bar, fruit cup and orange juice at home (total 330 kcal). Children will be asked to avoid consumption of any other food, with the exception of water, until arrival at the laboratory 3 hours later.

At the laboratory, five treatments of: (a) 2 whole eggs, (b) 2 egg whites, (c) 2 egg yolks, (d) full fat yogurt isocaloric to the 2 whole eggs, and (e) snack skipping will be provided to children 9-14 years on separate days at least 7 days apart. Cognitive performance, subjective emotion/mood, and subjective appetite will be measured for 90-minutes following snack consumption (n=25). Cognitive performance assessments will include learning and memory, spatial memory, attention and processing speed, and executive functions. In a subgroup of individuals (n=10), glucose, insulin, incretin hormones (glucagon like peptide1(GLP1) and gastric inhibitory polypeptide (GIP)),dipeptidyl peptidase 4 (DPP4), amino acids, fatty acids, and choline will be measured for 90-minutes following snack consumption.

Being tested
Snack skipping, Whole eggs, Egg whites, Egg yolks, Yogurt
Keywords
Children, Nutrition, Eggs, Cognitive performance, Glycemic response, Appetite, Emotion

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Snack skippingOther

    No snack provided

  • Whole eggsOther

    2 whole large eggs scrambled, provided as a snack

  • Egg whitesOther

    2 egg whites scrambled, provided as a snack

  • Egg yolksOther

    2 egg yolks scrambled, provided as a snack

  • YogurtOther

    A serving of full fat yogurt that is isocaloric to the 2 whole eggs

Study groups in NCT03321227
Study groupRoleWhat they receive
Snack skippingExperimentalNo snack provided
Receives: Other: Snack skipping
Whole eggsExperimental2 whole large eggs as a snack
Receives: Other: Whole eggs
Egg whitesExperimental2 egg whites as a snack
Receives: Other: Egg whites
Egg yolksExperimental2 egg yolks as a snack
Receives: Other: Egg yolks
YogurtActive comparatorFull fat yogurt as a snack
Receives: Other: Yogurt

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in memory from baseline

    One of five word lists composed of 15 words will be audio-visually presented to children. The majority of the words will be one syllable, and four words in each list will be two syllables long. The list will be presented at baseline and the children will be asked to recall as many words as possible at each time-point. The list will be presented for 2.5 minutes, and children will have 2 minutes for both immediate and delayed recall.

    Measured: 15, 30, 60, and 90 minutes

  2. Change in spatial working memory from baseline

    Assessed using a spatial pattern recognition test via the Membrain application. The test consists of a series of subtests where children will be presented a picture with patterns to study, and asked to identify a picture with the same pattern from a group of four images. This test will be at each time-point and takes approximately 1 minute to complete.

    Measured: 0, 15, 30, 60, and 90 minutes

  3. Change in attention from baseline

    The continuous performance task (CPT) will be completed via the Membrain application. During the CPT task, children will be given a sequence of two letters to identify; for example respond to the detection of the letter "X" only when it is preceded by the letter "A". This task will be at each time-point and will take 3 minutes total to complete.

    Measured: 0, 15, 30, 60, and 90 minutes

  4. Change in executive function from baseline

    The Stroop task will be completed via the Membrain application. Children will be presented with a list of words presented in colors that match the word (congruent, the word 'red' presented in red) or colors that do not match the word (incongruent, the word 'red' presented in blue). Children will be asked to identify the color of the word, not the word itself. The task is scored for the number of correct and incorrect colors identified, as well as total time to completion. This test will be at each time-point and will take 1 minute to complete.

    Measured: 0, 15, 30, 60, and 90 minutes

Secondary outcomes (10)
  1. Change from baseline mood

    Measured using visual analogue scale (mm). Each VAS is a 100 mm line where they will place a pencil mark to describe their feelings.These emotions will be seperated into three categories including, subjective emotions (aggressive, angry, excited, disappointed, and frustrated), global vigour and affect (alert, sad, tense, effort, happy, weary, calm and sleepy), and wellness. These sub scales will be combined to compute an average total score for each category.

    Measured: 0, 15, 30, 60, and 90 minutes

  2. Change from baseline subjective appetite

    Measured using visual analogue scale (mm). Each VAS is a 100 mm line where they will place a pencil mark to describe their feelings. Average appetite will combine four questions (desire to eat, hunger, fullness, and prospective food consumption) to calculate the score.

    Measured: 0, 15, 30, 60, and 90 minutes

  3. Change from baseline cholecystokinin (CCK)

    Blood CCK (pmol/L). CCK concentration in serum will be determined in duplicate via enzymelinked immunosorbent assay kits (ELISA; Millipore, Billerica, Massachusetts).

    Measured: 0, 15, 30, 60, and 90 minutes

  4. Change from baseline dipeptidyl peptidase 4 (DPP4)

    Blood DPP4 (ng/mL). DPP4 concentration in serum will be determined in duplicate via enzymelinked immunosorbent assay kits (ELISA; Millipore, Billerica, Massachusetts).

    Measured: 0, 15, 30, 60, and 90 minutes

  5. Change from baseline glucagonlike peptide1 (GLP1)

    Blood GLP1 (pmol/L). GLP1 concentration in serum will be determined in duplicate via enzymelinked immunosorbent assay kits (ELISA; Millipore, Billerica, Massachusetts).

    Measured: 0, 15, 30, 60, and 90 minutes

  6. Change from baseline insulin

    Blood insulin (pmol/L). Insulin concentration in serum will be determined in duplicate via enzymelinked immunosorbent assay kits (ELISA; Millipore, Billerica, Massachusetts).

    Measured: 0, 15, 30, 60, and 90 minutes

  7. Change from baseline glycemic response

    Blood glucose will be measured in whole blood using YSI 2300 STAT PLUS (YSI Incorporated, Yellow Springs, OH)

    Measured: 0, 15, 30, 60, and 90 minutes

  8. Change from baseline amino acids

    From plasma blood samples. Amino acids will be determined using the pre-column derivatization HPLC procedure. A plasma sample will be de-proteinizied with a 5-sulfosalicyclic acid solution, then centrifuged at 4°C and 18,400 G for 15 minutes. The amino acids will be derivatized from the sample with ortho-phthaldehyde reagent. The sample will then be analyzed using the Perkin Elmer Series HPLC System in the Ryerson University Analytical Centre.

    Measured: 0, 15, 30, 60, and 90 minutes

  9. Change from baseline fatty acids

    From plasma blood samples. Fatty acids will be assessed via gas chromatography, an effective method to measure both the proportions and concentrations of fatty acids in plasma. A plasma sample will be prepared by trans-esterification of total lipid aliquots with a MeOH/HCl mixture and n-hexane. The sample will then be analyzed using the Perkin Elmer Auto-System in the Ryerson University Analytical Centre.

    Measured: 0, 15, 30, 60, and 90 minutes

  10. Change from baseline choline

    From plasma blood samples. Will be analyzed for choline using a fluorimetric assay; free choline will be oxidized by choline oxidase to betaine and H2O2 that reacts with a specific dye to form a pink colored product. The fluorescence intensity at 530/585 nm is directly proportional to the choline concentration in the sample.

    Measured: 0, 15, 30, 60, and 90 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Oct 2017
  2. Study start9 Apr 2018
  3. Primary completion1 Dec 2018
  4. Study completion1 Dec 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Crossover
Model description
A random and within subject repeated measures experiment to study the effects of egg consumption on cognitive performance in children and the underlying physiological mechanisms in this relationship.
Masking
None (open label)
Enrolment
19 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03321227
Sponsor's protocol ID
Ryerson-REB-2017
Status last verified
Mar 2020
First submitted
18 Oct 2017
Last updated
11 Mar 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Snack skipping, Whole eggs and Egg whites in people with Nutrition and Cognitive Performance, run by Toronto Metropolitan University at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 11 Mar 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in memory from baseline (time frame: 15, 30, 60, and 90 minutes). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Mar 2020.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in